Fidelity Disruptive Medicine ETF FMED
32.05 USD +0.46 (+1.47%)
At closeNov 3, 2026, 4:00 PM EST
32.05 0.00 0.00%
After hours · Nov 3, 4:00 PM ET
31.75 Day range 32.37
23.48 52-week range 33.56
- YTD
- +18.48%
- 1 year
- +23.22%
- Market cap
- 72.12M
- EPS (ttm)
- 0.705577
- P/E ratio
- 45.42
- YTD return
- +18.48%
- 1-year return
- +23.22%
- Volume
- 12.20K
- Avg volume
- 8.43K
- Open
- 31.75
- Previous close
- 31.59
- Day's range
- 31.75 – 32.37
- 52-week range
- 23.48 – 33.56
2Y +6.37 (+24.66%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 25.84
- 200-day average
- 25.06
About Fidelity Disruptive Medicine ETF
The fund normally invests at least 80% of assets in securities of disruptive medicine companies. Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers. Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time. The fund is non-diversified.
News
Fidelity Investments® Announces Liquidation of Five Exchange-Traded Funds 
Innovative ETF Strategies That Are Paying Off This Summer 
Disruptive Healthcare Stocks ETF FMED Hits Milestone in June 
2 ETFs That Capitalize on the “Silver Tsunami” 
AI Opens The Door to This Active Healthcare ETF 
Investing in the Future of Healthcare 
Exploring Key Tailwinds for Fidelity's Disruptive ETFs 
First Look At FMED: Poor Performance Merits A Strong Sell Rating 
Agilon Health Adjusts To Recovery Phase, Analyst Is Cautious On Near-Term Fundamentals 
As Biotech Outlook Grows Healthier, Look to Disruptive ETF FMED
Your note
Sign in to keep a note on FMED — it syncs with the Stock Master app.